JULIE FRANCISCO: Open Payments
NPI 1457761736 · THOMASVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 18 payments from 10 companies in 2025. Trend: 2023 $443 · 2024 $59 · 2025 $573
Food & beverage: $473Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $149 |
| Janssen Biotech, Inc. | 3 | $116 |
| Tempus AI, Inc | 2 | $62 |
| GlaxoSmithKline, LLC. | 2 | $59 |
| Astellas Pharma US Inc | 2 | $50 |
| Janssen Scientific Affairs, LLC | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Incyte Corporation | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Eisai Inc. | 1 | $17 |
Products named: ERLEADA, XT CDX, Xtandi, OPDIVO, BLENREP, JEMPERLI, JAKAFI, Onivyde.
Industry payments across NC — which companies pay providers there.
